Nudep

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nudep

Property Description
Active Ingredient Sertraline Hydrochloride
Form Oral Tablet
Pharmacological Class Selective Serotonin Reuptake Inhibitor (SSRI)
Common Purpose Emotional regulation and mood stabilization
Origin Synthetic Compound

Nudep is a prescription-only, synthetic psychopharmaceutical medication. As a widely recognized trade name for Sertraline Hydrochloride, its identity is based on this single active component. The drug is often clinically recognized for its targeted support of mood stabilization in adult patients.


What Type of Medicine is Nudep?

Nudep belongs to the pharmacological class known as a Selective Serotonin Reuptake Inhibitor (SSRI). This classification confirms that the drug's mechanism is specifically engineered to primarily target and influence the processing of the serotonin neurotransmitter in the central nervous system. The SSRI class is recognized for its role in modulating chemical imbalances associated with emotional distress.

Sertraline: Composition, Form, and Origin

the active ingredient in Nudep is Sertraline Hydrochloride, which is a synthetic compound manufactured to ensure consistency and precision in its therapeutic effect. Nudep is generally prepared as an oral preparation in the form of a tablet, making it a single-component product designed for ingestion via the oral route. The standard tablet form is typically utilized for its ease of systematic delivery and precise dosing.

What is the General Purpose of Nudep?

The general purpose of Nudep is to promote a more stable and regulated mood by supporting the brain's ability to manage key chemical messengers. It functions through serotonin reuptake inhibition, which means the Sertraline component helps to increase the amount of active serotonin available to nerve cells. This action provides fundamental support for emotional regulation, such as helping a patient manage persistent symptoms of low mood, by affecting brain chemicals that may be unbalanced.

Regulatory References

  1. MedlinePlus Drug Information: Sertraline

What side effects are possible with Nudep?

Possible Side Effects and Safety Information

The safety profile for Nudep (Sertraline Hydrochloride) is comprehensively documented in official regulatory sources, with adverse reactions classified primarily by frequency and the body system affected.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their documented occurrence in clinical studies. Very Common reactions (affecting 1 in 10 patients or more) include nausea, insomnia, and ejaculation failure in men. Reactions classified as Common (affecting 1 in 100 to less than 1 in 10 patients) often involve gastrointestinal disorders (such as diarrhea and dry mouth), nervous system disorders (including tremor and dizziness), and general effects like fatigue and decreased appetite.


Serious Safety Considerations

The official labeling notes specific, potentially serious reactions. The risk of developing Serotonin Syndrome, a potentially life-threatening condition, is documented, particularly with the co-administration of other serotonergic agents. Furthermore, there is a noted risk of Hyponatremia (low sodium), with older adults considered to be at higher risk. Other serious adverse reactions listed include the activation of Mania/Hypomania, and an increased risk of bleeding.


Safety Constraints and Special Populations

Official regulatory documents include specific safety constraints, such as the contraindication with Irreversible Monoamine Oxidase Inhibitors (MAOIs) due to the risk of Serotonin Syndrome. Specific safety considerations are also documented for certain populations. For pediatric and young adult patients, there is an officially documented increased risk of suicidal thoughts and behaviors during short-term treatment. Discontinuation symptoms, such as sensory or sleep disturbances, are noted to potentially occur upon stopping treatment, suggesting a gradual dose reduction is necessary.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Nudep (Sertraline) overdose is defined by the spectrum of symptoms that can arise from excessive serotonin activity, and the mandate for aggressive supportive care.

Documented Overdose Presentations

Physiological Systems Affected Documented Overdose Manifestations
Central Nervous System (CNS) Somnolence, tremor, dizziness, agitation, confusion, seizures, and coma (loss of consciousness).
Cardiovascular/Autonomic Tachycardia (fast heartbeat), sweating, fever, and potential QTc interval prolongation.
Gastrointestinal Nausea, vomiting, and diarrhea.

The most severe manifestations, including coma, Serotonin Syndrome, and fatal outcomes, are nearly always associated with the co-ingestion of Sertraline with other drugs and/or alcohol, as noted in official regulatory documents. Furthermore, no specific antidote is known for Sertraline overdose, and treatment focuses on general symptomatic and supportive measures.

When Immediate Medical Help is Required

Regulatory authorities mandate that any overdosage must be medically treated aggressively. Urgent medical attention is required immediately if the individual: has collapsed, has had a seizure, has trouble breathing, or cannot be awakened. Contacting a Poison Control center is also an official recommendation for overdose management guidance.

Therapeutic Uses of Nudep

The medication is considered relevant across several therapeutic areas and is applied across domains where additional symptomatic support is needed.

Nudep is commonly used to help with symptoms across Major Depressive Disorder, Obsessive-Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Social Anxiety Disorder, and Premenstrual Dysphoric Disorder (PMDD). It is applied in addressing symptom clusters that include prolonged sadness, intrusive thoughts, and recurrent panic attacks. The medication may assist with managing these difficult, functionally disruptive episodes.

“The drug’s role is to help patients cope more steadily with symptom fluctuations and contribute to easing the overall symptom load.”

Quick Fact: Support for Obsessive-Compulsive and Fear Patterns

The medication is relevant in contexts marked by increased discomfort or tension. It is relevant for easing manifestations of hyperarousal and avoidance behaviors, assisting with maintaining functional stability when symptoms become temporarily overwhelming.

Regulatory References

  1. NIH MedlinePlus overview of Sertraline

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Nudep? — Official Regulatory Information

Populations for whom use is contraindicated

Nudep is strictly prohibited for use in patients with a history of hypersensitivity to its components, including dextromethorphan or quinidine. The medicine is also contraindicated for individuals with specific cardiovascular conditions, notably a prolonged QT interval, congenital long QT syndrome, heart failure, or complete atrioventricular (AV) block without a pacemaker. It must not be used with other quinidine-related drugs or with Monoamine Oxidase Inhibitors (MAOIs), requiring a 14-day washout period after stopping an MAOI.


Age-Related and Restricted Use Eligibility

Nudep is generally allowed for use in adults (age 18 and older). However, the safety and effectiveness have not been established in pediatric patients (under 18). For older adults, dose caution may be warranted due to the potential for decreased cardiac or organ function. In patients with severe hepatic or renal impairment, use is generally not recommended, and a careful assessment of risks versus medical necessity is required by regulatory agencies.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define specific combinations and conditions for Nudep (Sertraline) co-administration, based on documented interaction risks. These rules are non-advisory and reflect official label constraints.


Formal Contraindications

The following combinations are explicitly prohibited in regulatory labeling:

  • Monoamine Oxidase Inhibitors (MAOIs): Including irreversible MAOIs, Linezolid, and intravenous Methylene Blue, due to the risk of Serotonin Syndrome.
  • Pimozide: Prohibited due to the risk of QTc prolongation.
  • Disulfiram: Prohibited only with the Nudep Oral Solution, due to the formulation's alcohol content.

Clinically Significant Interactions

Nudep's profile includes documented risks from additive effects and metabolic changes:

  • Serotonergic Agents: Co-administration with medicines like Triptans, Fentanyl, Lithium, or Tramadol increases the official risk of Serotonin Syndrome.
  • Bleeding Risk: Co-administration with drugs that interfere with hemostasis, such as NSAIDs (Nonsteroidal Anti-inflammatory Drugs) or Warfarin, is associated with an increased risk of bleeding events.
  • CYP2D6 Inhibition: Sertraline is officially documented as a moderate inhibitor of the CYP2D6 enzyme, which can increase the plasma exposure of other medicines metabolized by this pathway.
  • Clearance Reductions: Substances like Cimetidine and conditions like Hepatic Impairment are documented to reduce Nudep clearance, increasing its exposure.

Timing Restriction

A 14-day mandatory washout period must elapse when switching between Nudep and an irreversible MAOI in either direction, as required by regulatory authorities.

Mechanism of Action

Selective Monoamine Transporter Modulation

This domain centers on the receptor- or enzyme-mediated signaling that involves specific neurotransmitter transporters in the central nervous system. Nudep's core mechanism is the selective inhibition of these transporters, which consequently increases the concentration of key monoamine neurotransmitters (like serotonin and/or norepinephrine) in the synaptic cleft. This action is relevant in biological systems where targeted pathway adjustment is required to regulate the concentration of these specific mediators.


️ Cascade Initiation and Synaptic Upregulation

The primary effect of reduced reuptake is an increased concentration of monoamines in the synaptic space, which initiates a crucial signaling cascade. The sustained elevation of these mediators leads to a subsequent functional adjustment and downregulation of certain inhibitory autoreceptors (like 5-HT1A or alpha2-adrenergic receptors) on the presynaptic neuron over time. This process is relevant in cascades where multiple layers of pathway activation occur, which results in an increased duration and magnitude of monoamine signaling at the synapse, influencing downstream receptor activity.


️ Modulation of Pathway Signaling

This mechanistic domain focuses on the influence of Nudep on the overall output of signaling pathways associated with heightened physiological responses. The modification of early molecular steps adjusts the equilibrium of mediator activity within the pathway, influencing the operational set point of the targeted neural network. The engagement of mechanisms that adjust pathway signaling leads to a modification of downstream physiological effects.

Dosage and Administration Information

How to Use Nudep: Official Administration Guidelines

This section outlines the standardized administration protocol for Nudep (Sertraline Hydrochloride), detailing the official usage patterns.


Administration Scope

Route of administration: Nudep is approved for the oral route only, via ingestion of tablets, capsules, or oral solution.

Dosing schedule (Adults):

  • Initial Dose: 50 mg/day is standard for major depressive disorder (MDD) and obsessive-compulsive disorder (OCD); 25 mg/day is used for panic disorder, PTSD, and social anxiety disorder.
  • Maximum Dose: The maximum daily dosage established across most indications is 200 mg per day.

Timing in relation to meals: Tablets may be taken with or without food.

Preparation requirements (if applicable): The oral concentrate (solution) must be diluted immediately before use with specific fluids only (water, ginger ale, lemon-lime soda, lemonade, or orange juice).

Age-group administration rules:

  • Pediatric Dosing (OCD): Initial dosing is 25 mg/day for children ages 6–12 years and 50 mg/day for adolescents ages 13–17 years.
  • Mild Hepatic Impairment: The recommended starting and maximum doses are officially half the usual dose.

Special procedural conditions: Dose adjustments (titration) must be made in 25 mg or 50 mg increments at intervals of at least one week. Capsules must be swallowed whole.


Connection to the Official Use Protocol

These administration guidelines establish a protocol focused on a slow, deliberate increase in the once-daily oral dose to reach a long-term maintenance level. This systematic process ensures the proper introduction of the medicine by mandating a minimum of one week between any dose changes and defining the official maximum limit. The protocol also includes specific rules for the correct preparation of the oral concentrate and adjustments for certain patient populations.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Nudep (Sertraline)


The following overview describes the types of clinical research that have been conducted to evaluate the use of Nudep (Sertraline) according to authoritative governmental and peer-reviewed sources. This summary focuses on the structure of the evidence and what studies have examined, without providing clinical advice or treatment recommendations.


Evidence for Use in Major Depressive Disorder (MDD)

The research base for the use of Nudep in conditions characterized by fluctuating or episodic manifestations of Major Depressive Disorder (MDD) is primarily composed of Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time in adults. Dedicated maintenance studies were conducted in patients with a history of recurrent depressive episodes to examine whether there was a difference in the measured recurrence rate compared to control groups. The data reflect patterns related to how symptoms evolved, and findings describe patterns observed in the studies, including measurements of remission rates.


Evidence for Use in Obsessive-Compulsive Disorder (OCD)

Nudep was studied for its use in Obsessive-Compulsive Disorder (OCD) through several double-blind, placebo-controlled RCTs, including those dedicated to pediatric patients (children and adolescents). Researchers examined outcomes describing episodic or acute changes in the intensity of obsessions and compulsions. For the pediatric population, the available evidence is limited and its quality varies across studies, with regulatory reviews noting that the measured outcomes were described as less pronounced in some short-term evaluations. Data are still emerging for long-term outcomes in this group.


Durability of Effect: Long-Term Studies and Follow-up

Research has explored how the observed symptom patterns hold up over time. Dedicated maintenance trials were conducted, primarily for Major Depressive Disorder, with follow-up durations ranging up to 18 months or more. Long-term effects are not fully established across all studied conditions. Long-term outcomes are not well characterized across all indications, and follow-up durations were limited in many initial trials.


Evidence Gaps and Areas of Research Uncertainty

Research provides context but not individual predictions. Data for certain groups, such as the pediatric population with OCD, remain insufficient for characterizing long-term effects. For conditions like Panic Disorder, comparative evidence is lacking regarding the long-term follow-up and studies examining the rate of symptom return. The study results reflect the specific conditions under which they were conducted, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. TRANSPARENCY COMMITTEE - ZOLOFT (Sertraline) - French National Authority for Health (HAS)

Frequently Asked Questions (FAQ)

Common questions about Nudep (FAQ)

Q: Is Nudep an antidepressant or something else?

A: Nudep (sertraline) belongs to a class of medicines called Selective Serotonin Reuptake Inhibitors (SSRIs). This classification indicates that the drug primarily influences the serotonin neurotransmitter system. Official product information confirms that Nudep is approved for treating Major Depressive Disorder, as well as several anxiety and mood-related disorders.

Q: How long does it typically take to feel the effects of Nudep?

A: The full therapeutic effect of Nudep is not immediate. Regulatory information indicates that it may take 4 to 6 weeks of consistent daily use before the full extent of the therapeutic effect may be observed. Initial improvements in physical symptoms like sleep, energy, or appetite may sometimes be noticed earlier.

Q: Does Nudep start working right away?

A: No, Nudep does not start working right away. The levels of the drug in the body take about one week to stabilize. Because the medicine works by making functional adjustments in the brain over time, the full therapeutic effect is typically observed only after several weeks of continuous use.

Q: Will I need to take Nudep forever?

A: Official regulatory documents indicate that Nudep is approved for both the initial acute treatment and for long-term maintenance treatment for certain approved conditions. The duration of therapy is not fixed; treatment plans are generally defined based on the specific condition and individual clinical status.

Q: What kinds of food or drink interact with Nudep?

A: Regulatory documents state that taking the Nudep tablet form with food can result in a slight increase in the amount of the drug absorbed by the body. Beyond this timing suggestion, the medicine can generally be taken with or without a meal.

Q: Are there any common over-the-counter medicines that interact with Nudep?

A: Interactions may occur with other medicines that affect the central nervous system or increase serotonin levels. Regulatory documents recommend that all medicines, including over-the-counter products, be reviewed in the context of the treatment plan, as some combinations may carry increased risks.

Q: Does Nudep interact with alcohol?

A: According to the official product information, the concomitant use (using together) of Nudep (sertraline) and alcohol is not advised. This guidance reflects warnings regarding potential interactions.

Q: Can Nudep be used by children?

A: The drug is officially approved for the treatment of Obsessive-Compulsive Disorder (OCD) in pediatric patients aged 6 to 17 years. The medicine is included in treatment protocols for this population, which include specific administration schedules and required supervision.

Q: What does the research evidence say about how well Nudep works?

A: Official regulatory documents contain summaries of controlled clinical trials that were used to determine the drug's effectiveness. These summaries detail the specific efficacy endpoints (measurements) and results observed during clinical assessment when compared to placebo in the approved patient populations.

Q: What should I expect in the first week of using Nudep?

A: Drug levels reach a steady state in the body in about one week, which is when many initial side effects may become noticeable. Official warnings highlight the risk of suicidal thoughts and behaviors that can emerge or worsen when starting treatment, especially in young adults.

Q: Can Nudep cause dizziness or drowsiness?

A: Yes, regulatory documents list dizziness (somnolence) as a common side effect reported in clinical trials. It is noted that this effect may temporarily impact the ability to perform tasks that require concentration.

Q: What are the long-term side effects noted in official literature for Nudep?

A: While long-term safety data continues to be collected, clinical studies have specifically reported certain lasting effects. These include reports of changes in weight (gain or loss) and potential reports of sexual dysfunction with extended use.

Q: How long does Nudep stay in your system after stopping?

A: According to the pharmacokinetics section of the official label, the average terminal elimination half-life of sertraline is approximately 26 hours. This is the time it takes for half of the drug to be eliminated from the body.

Q: What happens if I forget to take Nudep?

A: Official patient information outlines a standardized procedure for a missed dose, which typically involves taking the dose as soon as possible unless it is nearly time for the next scheduled dose, in which case the missed dose is skipped.

Q: Can Nudep cause changes in weight?

A: Yes, official adverse reaction reports confirm that changes in weight are possible. Both weight loss and weight gain have been reported as adverse reactions observed in the drug's clinical trials.

Q: Is it common to have headaches when first starting Nudep?

A: Yes, official adverse reaction reports indicate that headache is listed as one of the very common adverse reactions reported during clinical studies, which may be reported when initiating the medication.

Q: Can Nudep be taken with herbal supplements?

A: Regulatory documents advise caution with certain supplements. Herbal remedies that are known to increase serotonin, such as St. John's wort, are advised against due to the potential risk of increasing serotonin-related side effects.

Q: Is Nudep considered safe for women who might become pregnant?

A: The official prescribing information provides data and warnings on using the drug during pregnancy. It notes that use, particularly late in pregnancy, may be associated with risks for the newborn, such as persistent pulmonary hypertension.

Q: What are the official guidelines regarding Nudep use while breastfeeding?

A: Official regulatory documents indicate that small amounts of Nudep and its active metabolite are known to pass into breast milk. The prescribing information contains data on this transfer and the resulting concentration in infants.

Q: Why do some people report feeling worse when they first start Nudep?

A: The product carries a Boxed Warning that highlights the risk of suicidal thoughts and behaviors that can emerge or worsen, particularly in children and young adults, when initiating treatment or following dose adjustments.

Q: Is Nudep habit-forming or addictive?

A: Nudep (sertraline) is not a controlled substance and does not have the abuse potential associated with those drugs. However, the regulatory label notes that physical dependence can occur, which means stopping the drug suddenly can lead to discontinuation symptoms.

Q: Is Nudep a controlled substance?

A: No, Nudep (sertraline) is not classified as a controlled substance by regulatory agencies.

Q: Does Nudep need to be taken at a specific time of day?

A: The official dosage and administration instructions state that the drug is typically dosed once a day. The choice between morning or evening is generally based on the established clinical schedule.

Q: What kind of monitoring is needed when taking Nudep?

A: Official warnings state that patients must be closely monitored, especially during the first few months of treatment or following dose changes. This monitoring focuses particularly on potential worsening of depression and the emergence of suicidal thoughts and behaviors.

Q: Can Nudep affect concentration or focus?

A: Regulatory documents confirm that the drug can cause side effects like drowsiness or dizziness. These effects may potentially interfere with activities requiring attention and focus.

Q: What is the maximum duration of use described in official documents?

A: Official clinical studies have evaluated Nudep for maintenance treatment for periods exceeding 12 weeks. This indicates that the maximum duration of use is not a fixed number and is based on individual clinical need.

Q: Does Nudep interact with birth control pills?

A: Regulatory drug-drug interaction studies with hormonal oral contraceptives have been performed. The official text does not indicate that Nudep causes a clinically significant interaction that would compromise the effectiveness of birth control pills.

Q: What should I do if I have a persistent side effect while taking Nudep?

A: Official patient counseling information advises that any new or worsening symptoms, or any persistent side effects, should be reported to a healthcare professional. This reporting procedure is standard practice for medication management.

How should Nudep be stored and disposed of?

How to Store and Dispose of Nudep: Official Regulatory Requirements

The storage and disposal instructions for Nudep are defined by official regulatory labeling to maintain product stability and ensure public safety.

Storage Conditions

Requirement Official Regulatory Statement
Temperature Store at controlled room temperature, typically between 15 C and 25 C (59 F and 77 F).
Protection Keep the medicine in its original container, protected from excessive moisture and light.
Handling Do not freeze. Keep out of the reach of children.

Disposal Instructions

Expired or unused Nudep must be disposed of according to the official product instructions. Disposal is typically prohibited in household trash or down the sink/toilet to prevent environmental contamination. The official guidelines often require returning the medication to a local pharmacy, an authorized drug take-back site, or following specific procedures for controlled waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nudep found in:

A-Z Index: